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STUDY QUESTION: What is good practice in ultrasound (US), and more specifically during the different stages of transvaginal oocyte
retrieval, based on evidence in the literature and expert opinion on US practice in ART?
SUMMARY ANSWER: This document provides good practice recommendations covering technical aspects of US-guided transvaginal oocyte
retrieval (oocyte pick up: OPU) formulated by a group of experts after considering the published data, and including the preparatory stage of
OPU, the actual procedure and post-procedure care.
WHAT IS KNOWN ALREADY: US-guided transvaginal OPU is a widely performed procedure, but standards for best practice are not
available.
STUDY DESIGN, SIZE, DURATION: A working group (WG) collaborated on writing recommendations on the practical aspects of
transvaginal OPU. A literature search for evidence of the key aspects of the procedure was carried out. Selected papers (n = 190) relevant to
the topic were analyzed by the WG.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The WG members considered the following key points in the papers: whether
US practice standards were explained; to what extent the OPU technique was described and whether complications or incidents and how
to prevent such events were reported. In the end, only 108 papers could be used to support the recommendations in this document, which
focused on transvaginal OPU. Laparoscopic OPU, transabdominal OPU and OPU for IVM were outside the scope of the study.
MAIN RESULTS AND THE ROLE OF CHANCE: There was a scarcity of studies on the actual procedural OPU technique. The document
presents general recommendations for transvaginal OPU, and specific recommendations for its different stages, including prior to, during and
after the procedure. Most evidence focussed on comparing different equipment (needles) and on complications and risks, including the risk
of infection. For these topics, the recommendations were largely based on the results of the studies. Recommendations are provided on
equipment and materials, possible risks and complications, audit and training. One of the major research gaps was training and competence.
This paper has also outlined a list of research priorities (including clarification on the value or full blood count, antibiotic prophylaxis and flushing,
and the need for training and proficiency).
LIMITATIONS, REASONS FOR CAUTION The recommendations of this paper were mostly based on clinical expertise, as at present,
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focusing on OPU were heterogeneous with significant difference in techniques used, which made drafting conclusions and recommendations
based on these studies even more challenging.
WIDER IMPLICATIONS OF THE FINDINGS: These recommendations complement previous guidelines on the management of
good laboratory practice in ART. Some useful troubleshooting/checklist recommendations are given for easy implementation in clinical
practice. These recommendations aim to contribute to the standardization of a rather common procedure that is still performed with great
heterogeneity.
STUDY FUNDING/COMPETING INTEREST(S): The meetings of the WG were funded by ESHRE. The other authors declare that they
have no conflict of interest.
TRIAL REGISTRATION NUMBER: NA.
ESHRE Pages content is not externally peer reviewed. The manuscript has been approved by the Executive Committee of ESHRE.
Key words: good practice / recommendations / ultrasound / oocyte retrieval / oocyte pick up / ART / guideline / needle / competence
/ quality
WHAT DOES THIS MEAN FOR PATIENTS?
Removal of eggs from the ovaries under US guidance (oocyte recovery) is a minor surgical procedure, which is commonly performed as a part
of IVF, but there are few agreed standards for best practice. The current paper describes practical recommendations for oocyte recovery, so
that clinicians can make sure that the procedure is done correctly and safely. Advice is provided on how best to provide care prior to, during
and after the procedure, as well as on the most appropriate equipment and materials. The authors also consider possible risks, training needs
and ways of checking the quality of care.
Introduction
The World Health Organization (WHO) estimated that 48.5 million
couples worldwide are affected by infertility (Mascarenhas et al., 2012).
During fertility treatment, women need an ultrasound (US) approach
for both diagnostic and therapeutic procedures, which can be per-
formed with either a transvaginal or a transabdominal approach (Lutz
and Buscarini, 2013). Results of the images obtained during these scans
are vital for the patient’s care, as they might impact on which treatment
protocol the patient will follow and on the treatment outcome. This is
why the operator’s findings and approach play an essential role in the
treatment of the clinical problem.
During the early days of IVF, oocyte retrieval was systematically
performed by laparoscopy. This required a surgical procedure, gen-
eral anaesthesia and hospital admission. After the first reports on
transvaginal oocyte retrieval in the early 1980s (Gleicher et al., 1983;
Dellenbach et al., 1984; Schulman et al., 1985), oocyte retrieval is
almost always performed transvaginally. The advantages of transvaginal
oocyte retrieval, in comparison with the transabdominal or laparo-
scopic approach, include:
– better visualization and shorter distance of ovary from the
transducer,
– high recovery rate of good-quality oocytes with minimal discom-
fort for patients,
– the use of local anaesthesia with sedation instead of general
anaesthesia,
– decreased risk of intestinal trauma,
– it can be easily learned, especially by operators trained in US,
– decreased costs for patients
– and quick post-interventional recovery.
However, in some patients, transabdominal US facilitated access








































































brim. Transabdominal-guided oocyte retrieval continues to be used
at some centres for rare patients who have ovaries inaccessible by
transvaginal US.
Nowadays, transvaginal oocyte retrieval is a widely performed pro-
cedure, with a low complication rate (European IVF monitoring Con-
sortium for the European Society of Human Reproduction and Embry-
ology et al., 2017). In this paper, recommendations for different steps
of transvaginal oocyte retrieval will be described. Laparoscopic oocyte
retrieval, transabdominal oocyte retrieval and oocyte retrieval for IVM
are outside the scope of this document.
The recommendations for good practice in this paper were based
on evidence (where available) and experts’ opinions on US practice
in ART. This paper is aimed to guide clinicians, especially in countries
where there are no national guidelines, and it could have a significant
impact on patients’ care and safety worldwide.
Materials and Methods
The current recommendations were written by a working group (WG)
of experts on US, according to the methodology described in the
manual for development of recommendations for good practice (Ver-
meulen et al., 2018).
The current document’s first draft was based on the results of the
doctoral thesis of one of the authors (C.P.) (Panayotidis, 2017). C.P.
conducted a systematic review of the literature and a Delphi survey of
15 experts reporting their opinions on current practice in US-guided
oocyte retrieval. The Delphi method survey included 53 questions
completed in three rounds and resulted in 32 standards of practice.
In addition to the results of the dissertation, a new literature search
was conducted. Databases (PUBMED/Medline and the Cochrane
Library) were searched from inception to 17 July 2018. Search
terms focussed on US, oocyte retrieval/pick up, Doppler, sedation,
anaesthesia, infection, antibiotics, hydrosalpinx and flushing, and
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Figure 1 Basic principles of the OPU technique. OPU: oocyte pick up.
included extended key words, commonly used synonyms and MESH
terms. References were divided according to topic, and full texts
were assessed (Supplementary Fig. S1). Where possible, references
of papers providing indirect evidence or referrals to other guidelines
were added, based on expert opinion.
The first draft of the paper, based on the dissertation, was pre-
sented and discussed by the WG during a teleconference in November
2017, after which WG members submitted their written comments
and suggestions for improvement. A full-day consensus meeting was
organized to discuss the paper further until consensus. The results
of the literature search were included where relevant. The document
was published on the ESHRE website for 4 weeks (between 25 March
and 23 April 2019), and stakeholders were invited to submit their
comments. After addressing all comments from the stakeholder review
(report available on www.eshre.eu/guidelines), the document was
finalized and approved by the ESHRE Executive Committee.
The paper outlines recommendations for good practice in oocyte
retrieval, with addition of further basic information, checklists and
troubleshooting in Figs 1–6. For ease of use of the recommendations,














































OPU is defined as follows: OPU is an US-guided technique in which
oocytes are aspirated using a needle connected to a suction pump.
There are different terms and abbreviations used in clinical practice
and research to describe the collection of oocytes in ART, including
(transvaginal) oocyte retrieval, egg retrieval, oocyte collection and
follicle aspiration. The WG suggests for further use of the term ‘OPU’,
to increase consistency, facilitate literature searches and further assess
best clinical practice in performing OPU.
The current paper outlines recommendations for good practice in
OPU and is sub-divided into the following sections:
– Prior to OPU




– Associated pathologies and cautions during OPU
– Complications and risks
– Future developments
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Figure 2 Before OPU checklist.
– Training and competence
– Quality assurance and performance.
Some general aspects of the OPU technique are outlined in Fig. 1.
Prior to OPU
Pelvic US
– An US evaluation should be performed before starting an ART
treatment: to decide the ovarian stimulation protocol; to deter-
mine whether there is any anatomical abnormality or a mal-
position of the ovaries (Grimbizis et al., 2016) and to assess
ovarian placement and ovarian/follicular accessibility after previ-
ous surgery (gynaecological surgery for myomas, endometriomas,
adhesions). A basic diagnostic US examination also allows for the
detection of recent lesions, such as endometrial abnormalities or
ovarian cysts, in a timely manner. In addition, such transvaginal
diagnostic US is of value to visualize not only the ovaries, but also
the uterus and to check for potential difficulties during OPU. The
accessibility of the ovaries and follicles and any potential compli-
cations or difficulties of the OPU should be clearly documented
in the patient case notes, for the team to be prepared and for the
patient to be counselled accordingly.
– Pre-OPU 3D US and Doppler investigation are considered helpful
for the operator to become familiar with the anatomy of the
patient and to prevent (vascular) complications.
– The time frame to perform the US is at the discretion of the clini-
cian. The American Institute of Ultrasound in Medicine (AIUM)
guidelines suggest a comprehensive sonographic evaluation of
the pelvis within 4–6 months from the start of ovarian stim-
ulation (American Institute of Ultrasound in Medicine, 2017).





































































ditions (endometriosis, surgery, specific symptoms). The WG
recommends a baseline US closer to the OPU to highlight any
difficulties or reconfirm previous findings, for example, shortly
before starting the ovarian stimulation with gonadotrophins.
Vaginal infection screening
– Screening for vaginal infection (by taking a vaginal sample for
bacteriological examination) should be performed during diag-
nostic work-up and can be required based on local guidelines
and regulations. However, the incidence of vaginal infections after
OPU is low, and several aspects of vaginal screening and treatment
remain unclear in asymptomatic patients without a history of
pelvic infections, including the relevance of the screening tests, the
implications of treatment before OPU and the impact on future
pregnancy (Amso, 1995; Matorras et al., 2018).
– In women with symptoms of infection, it is recommended to
perform specific testing for cervical and vaginal infections and take
appropriate actions.
Patient medical history
– As OPU is performed under sedation or anaesthesia, a full blood
count (FBC) and any additional test can be ordered, depending
on local regulations regarding pre-operative management. There
is no evidence suggesting value for an FBC or any additional test
before OPU with regard to preventing complications.
– Taking accurate patient history before OPU is essential to highlight
potential comorbidities and take actions to prevent any possible
associated complications. Patients should at least be asked about
the use of medications—more specifically the use of blood thin-
ning agents (aspirin and others), relevant previous surgeries and
any relevant disease or deficit of coagulation factors.
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Figure 3 Troubleshooting during OPU.
Information provision and informed consent
– Recent or confirmation of (written) informed consent for treat-
ment should be obtained according to local regulations.
– Verbal and written information should be provided to patients,
according to local templates, explaining the procedure, the risks
and their incidence. Counselling should be provided regarding
additional risks associated with specific diagnostic or incidental
findings.
Equipment and consumables
During the OPU, the operator should be equipped as required by
European standards and local regulations.
The following equipment for OPU should be available on a sterile
operation table: sterile small gauzes and a disposable or reusable
speculum for cervical examination and to visualize any bleeding site.
Furthermore, a test tube warmer and heating block should be available
(at 37◦C), and culture medium for flushing should be prepared and
ready at 37◦C. Additional equipment and consumables that might be















































as ovary clamps, sponge holder, vaginal surgery equipment, including
(absorbable) sutures. Resuscitation equipment, reversal anaesthetic
drugs, a prepared kit for anaphylactic shock treatment and oxygen
should also be available in (the near proximity of ) the procedure room.
All equipment, materials and consumables used should be compliant
with the European standards.
US system and transducer
– The US system should be fit for OPU with a high-frequency
transvaginal US transducer, which offers the best quality in real-
time imaging of the field of view.
– The US system should have the ability to adjust the field of
view depth and zoom; adjust the focal zone to the region
of interest (except where image processing techniques have
dispensed with this feature); adjust the acoustic power, colour
and power Doppler capabilities; display the mechanical and
thermal indices on screen; display the needle guide super-
imposed on the field of view; and print or save images/cine
loops in the system’s hard drive or a central picture archiving
and communication system include image gain adjustment
controls.
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Figure 4 After OPU checklist.
Figure 5 Assessing competency.
– The software of the system should be up to date, the system
should be calibrated regularly and it should be serviced accord-
ing to the manufacturer’s instructions and any local institutional
requirements. To ensure safety, the system should be replaced in
a timely manner, as recommended by the manufacturer.
– Some manufacturers have introduced software that automatically
counts and calculates the mean diameter and volume of follicles.
Caution should be taken in correlating these new parameters with
oocyte maturity in comparison with conventional mean follicular
diameter.
– The transvaginal transducer, or probe, should have a frequency
range of 5–8 MHz and an abdominal transducer with a frequency
range of 2–6 MHz, or their contemporaneous equivalents at the
time of purchase.
– An appropriate protocol for transducer disinfection should be
established, in accordance with manufacturer’s instructions. OPU
operators and assistants should be familiar with the disinfection
technique and keep a detailed documentation of the disinfection
procedure.
– The transducer should be designed for easy application of a
specific sterile cover, incorporating a good-quality sonographic gel
on the tip of the transducer.
– An appropriate transducer cover should be used, powder-free
and compatible with the US device, as this may affect the quality
of the image. A latex-free cover should be used in case of latex
allergy.
– The use of lubrication (on the outside of the cover) does not





























































avoided as there is a hypothetical gametotoxic and embryotoxic
effect. When needed, sterile water or culture media can act as
lubricant and conductor of US waves.
Needle
– A single-lumen 17- or 18-gauge needle is the most commonly
used one for OPU. However, needles of different sizes and shapes
with different flexibility exist. It seems that needles with a smaller
diameter provoke less discomfort to the patient (Aziz et al., 1993;
Awonuga et al., 1996).
– Needles with edging are recommended. The operator should be
able to see the needle edge tip and know how to recognize it
during the US investigation.
– Translucent tubing should be attached to the needle to enable the
operator to see the content and the colour of the fluid aspirated.
– The needle guide should ideally be disposable and attached at the
tip and the bottom of the transducer.
– Double-lumen needles, or variations of them, can also be used.
With these needles, oocyte collection media is infused into the
follicle at the same time as the follicular fluid is being aspirated.
– The operator should be familiar with the design and the sharpness
of the needle.
– The needle patency and aspiration ability should be checked
before insertion into the guide and prior to OPU (Fig. 2).
Suction pump and pressure
– The suction pump creates a negative pressure for aspirating
follicles. At present, there is no conclusion on the optimal aspi-
Good practice in US-guided OPU 7
Figure 6 Recommendations for future research in OPU. FBC: full blood count.
ration pressure level, and a variety of pressures between 100 and
200 mmHg are used, often based on manufacturer’s instructions
(Panayotidis, 2017; American Institute of Ultrasound in Medicine,
2017). In a single study, higher pressures (140 mmHg) were not
associated with damage to the oocytes (Kumaran et al., 2015).
– The suction pump should be validated prior to use, and a spare
suction pump should be available in case one does not work.
– A stable pressure should be maintained during the procedure,
as changes can induce turbulence. Changes in pressure can be
acceptable in cases of needle blockage.
Further research is needed, and an auditable record of the needle
and pressure characteristics correlated with the oocyte yield would be
helpful.
OPU preparation
The team performing the OPU should consist of at least the operator
and one assistant or nurse. It is recommended that at least one person
in the room is trained in advanced life support (Hinkelbein et al., 2018).
The identity of the patient should be checked, and the WHO
surgical safety checklist (time out) applied (World Alliance for Patient
Safety, 2008).
Ovarian stimulation
It is important that OPU is performed according to a precise timing.
Most authors recommend a 36-h interval between medical triggering
and OPU, but intervals between 34 and 38 h have been applied (Weiss
et al., 2014).
– Immediately before OPU, patients should be specifically asked
about the timing of hCG or GnRH agonist injection. In case it
is not clear whether the patient has had hCG administered, an
hCG immunology urine test or serum beta-hCG test should be















































































inadequate hCG administration (Matorras et al., 2012). The WG
does not suggest routine hCG testing for all patients before OPU.
– In agonist trigger cycles, the baseline serum level of LH should be
measured on the day of the trigger. If no oocytes are found during
OPU, LH levels can be checked and compared with baseline LH
levels. If LH levels are below 0.5 mIU/ml, the trigger should
be repeated with recombinant hCG instead of GnRH agonists
(Meyer et al., 2015).
– In patients undergoing OPU under general anaesthesia and/or
undergoing a natural cycle where there was the development of
only a few follicles and/or when there are concerns of premature
ovulation, transvaginal US should be performed before starting
the procedure.
Patient position and preparation for the procedure
– The patient must fast, 6 h for food and 2 h for clear fluids (see also
section sedation).
– A peripheral intravenous line should be established, with Ringer’s
lactate solution or physiological saline solution at the minimum
speed required in order to keep the vein open. Correction of
blood glucose levels and any other infusions should be performed
according to local protocols.
– The patient must empty her bladder immediately prior to OPU.
An empty bladder improves the image quality during transvaginal
examination as it decreases the posterior enhancement (US arte-
fact), whereas a full bladder can distort the anatomy of the uterus
and ovary and may increase the risk of injuries.
– Patient positioning during OPU needs to be comfortable for both
patient and operator.
– Gynaecological positioning in the semi-lithotomy or lithotomy
position can facilitate the OPU manoeuvre. The position of the
patient may need to be adapted to patient mobility.
– The operator can be seated or standing during the OPU
procedure.
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Table I List of abbreviations used in the text......................................................................................
3D Three-dimensional
AIUM American Institute of Ultrasound in Medicine








hCG Human chorionic gonadotrophin
HIV Human immunodeficiency virus
IV Intravenous
IVF In vitro fertilization
IVM In vitro maturation
LH Luteinizing hormone
OHSS Ovarian hyper-stimulation syndrome
OPU Oocyte pick up
PACS Picture archiving and communication system
PCOS Polycystic ovary syndrome
PCSA Patient controlled sedation/analgesia
PID Pelvic inflammatory disease
RCOG Royal College of Obstetricians and Gynaecologists





WHO World Health Organization
Speculum examination
– Speculum vaginal and cervical examination should be performed
before OPU to check normal anatomy and exclude any new
leucorrhoea, polyp or other conditions that could interfere with
the procedure.
Disinfection
– Cleansing of the vagina/cervix should be done prior to OPU to
minimize bacterial vaginal/cervical contamination. Vaginal cleans-
ing is commonly done with (warmed) normal saline (Ludwig
et al., 2006; Tobler et al., 2014). Other vaginal preparations are
used (e.g. 0.5% chlorhexidine solution, povidone iodine or culture
medium), but there is no evidence on safety or superiority to
normal saline. Furthermore, these agents may act on the cell
membrane and not be safe for oocytes (Mangram et al., 1999).
Povidone–iodine preparations have been shown to be toxic to
murine oocytes/embryos (Hershlag et al., 2003).
– Further studies are needed on the safety of antiseptic methods,





























































































































and post-OPU complications (Tsai et al., 2005; Funabiki et al.,
2014).
Sedation
Sedation is categorized as a ‘continuum’ (Apfelbaum et al., 2018)
(Supplementary Table SI available at Human Reproduction Open online).
For ambulatory procedures, conscious sedation is preferable for the
patients as their recovery times are shorter in comparison with general
anaesthesia (Piroli et al., 2012). Therefore, OPU under conscious
sedation is usually a suitable option for patients and operators alike
(Kwan et al., 2018).
Patient selection is an important consideration. Although conscious
sedation is a well-tolerated option for most patients, in some circum-
stances, deep sedation could be preferable such as in cases of:
– extreme anxiety,
– associated pathologies that can complicate OPU, making the
procedure longer or painful such as in extensive endometriosis,
pelvic adhesions, ovaries with many follicles or ovaries that are
difficult to access,
– patients with associated personal, psychological or social condi-
tions (medical fertility preservation, oocyte donors, transgenders)
– and issues with conscious sedation in previous attempts.
On the other hand, OPU could be performed more easily under
conscious sedation in:
– Obese patients, where intra-abdominal pressure and abdominal
respiration can occur. This could make stimulated ovaries move
up and down, which would then complicate OPU.
– Patients where the deep sedation induced hiccups, which pro-
duces ovarian movement, which can jeopardize OPU. However,
hiccups can rarely be foreseen before OPU.
An escalation policy must be in place where an anaesthetist is
available for advice. The team can then decide whether sedation or
a general anaesthetic should be considered in difficult cases, or if the
patient requests it. The risk benefit must be discussed and taken into
consideration, including the hypothetical effect of the anaesthetic drugs
on the oocyte quality, airway difficulties, airway reflex loss for up to
4 h post-procedure due to a supra-glottic mask airway devices or
intubation and longer recovery times. For these reasons, all patients
undergoing OPU fast as before a general anaesthetic, 6 h for food and
2 h for clear fluids (Checketts, 2016).
For a general anaesthetic to take place, a full anaesthetic team
for safety of the patient (an anaesthetist and operation department
personnel or an anaesthetic nurse) needs to be present during OPU,
and the procedure needs to be carried out in an appropriate setting,
which may affect timing of procedures and cost and cause delay in
treatment (Youn et al., 2015).
Overall, evidence does not support one particular method or tech-
nique over another (Kwan et al., 2018). Different options should be
discussed with the patients; patient preference (including cultural pref-
erences) should be considered, as well as patient selection. Important
consideration must be given to the risk versus benefit with sedation
and general anaesthesia. Further studies on complication rates related
to the OPU performance under sedation versus general anaesthesia
are needed. Specific recommendations for good practice for sedation
in assisted conception were recently published by the British Fertility
Good practice in US-guided OPU 9
Table II Further information on different types of sedation.
Conscious sedation
......................................................................................................................................................................................
During conscious sedation, the patient should be able to communicate with personnel and be able to follow orders, for example ‘Breathe deeply’. All
respiratory and cardiovascular parameters should remain intact.
Conscious sedation involves the following options:
Normal conscious sedation (not with an anaesthetist or sedationist with anaesthetic skills) may require:
• Midazolam 1 mg/ml to give no more than 7 mg in divided doses with Fentanyl (2 ml, 100 mg diluted with 8 ml of normal saline to make a dilution of
10 mcg/ml). When giving this combination Fentanyl must be given first as the synergy increases the potency of Midazolam by 8×.
• If needed supplementary doses of 20 mcg Fentanyl can be given during the procedure up to a maximum of 100 mcg (not exceeding 1 mcg/kg).
Anaesthetic conscious sedation (with an anaesthetist or sedationist with anaesthetic skills) may require:
• Propofol 1% 18 ml combined with Alfentanil 1 mg (2 ml) to provide a dilution of 50 mcg/ml.
• Midazolam is not advised due to synergism with Propofol causes the potency of Propofol to increase by over 50% (Short and Chui, 1991)





A para-cervical block can be applied in addition to sedation, as pain relief during the OPU. It appears to be superior when compared with sedation alone
(Kwan et al., 2018). A local anaesthetic agent is usually deposited in four locations around the cervix in the vaginal mucosa. In total 100 mg lidocaine (10 ml of
1% lidocaine, xylocaine 10 mg/ml) is injected at two (3 and 9 o’clock) or four points around the cervix. Other authors employ two para-cervical locations
(without further sedation or analgesia) with good results (Rolland et al., 2017; Kwan et al., 2018). Satisfaction with the procedure was higher when the blocks
were used during a general anaesthesia and post-operative pain was also lower (Rolland et al., 2017).
.......................................................................................................................................................................................
Other forms of anxiolysis
.......................................................................................................................................................................................
– VA by the sedationist is a very important part of any OPU that is performed with conscious sedation and/or local anaesthetics (Gange and Baum, 2017). VA
is a conversational distraction associated with measures to ensure a calming environment, thereby reducing pain, anxiety, and stress. Good VA begins with
clear preoperative communication. It is important to set patient expectations at the time of scheduling; the role of the ‘verbal anaesthetist’ is to begin to set
the tone with calming conversation while taking the patient into the room. The environment can be made more relaxing with darkened lights, music in the
background and care taken to ensure that the room temperature is made comfortable (21–23◦C) (Yeo et al., 2013; Zhang et al., 2014; Cho and Choi,
2016). It is commonly used in in-office procedures of many disciplines but is poorly described in the literature.
– Hypnosis is another form of anxiolytic, which can be used to achieve better patient satisfaction, fewer complications and less drug usage (Faymonville et al.,
1995).
VA, verbal anaesthesia.
Society (Acharya et al., 2019). Further information on different types
of sedation is provided in Table II.
Monitoring: Non-invasive blood pressure and pulse oximetry must be
used when drugs have been administered intravenously; electrocardio-
gram and CO2 monitoring are developmental standards for conscious
sedation but are minimal monitoring standards for deep sedation and
general anaesthesia (Checketts, 2016).
Post-operative analgesia: Most studies have reported very little
difference in effectiveness of analgesia administered before starting
the procedure versus immediately after starting the OPU. The
most favourable post-operative pain management is that of a multi-
modal peri-operative approach, using intra-operative analgesia with
opiates and local anaesthetic block with oral/IV/per rectal medication
(Vadivelu et al., 2014). Post-operative analgesia can consist of the
following:
– Oral paracetamol 1 g + codeine 60 mg is shown to be more
effective than paracetamol alone (Zhang and Li Wan Po, 1996).
– Non-steroidal anti-inflammatory drugs can be given (if no con-
traindications) about 1–1.5 h prior to the procedure.
– Per rectal diclofenac (100 mg) can be given post-procedure,
followed by IV paracetamol (15 mg/kg) in the recovery. Whether
given orally or rectally, this has the same post-operative analgesic






















































It is not exceptional that the semen sample cannot be obtained on
the day of OPU. Sperm collection at home or storing a previously
obtained sperm sample as a back-up is advisable. If a back-up sample
is not available, oocyte cryopreservation, or further options for sperm
retrieval (administration of sildenafil, or surgical sperm retrieval) can be
considered. In any case, patients should be counselled on the possibility
of such complications and informed consent should be obtained before
starting the OPU procedure.
Antibiotic prophylaxis
Patients with a history of endometriosis, pelvic inflammatory disease
(PID), pelvic adhesions, dermoids or previous pelvic surgery can be
considered at high risk for pelvic infection. In these patients, adminis-
tration of antibiotics is recommended shortly before or during OPU
(according to local protocols).
There is no evidence for the use of antibiotic prophylaxis in low-
risk patients, and this can be decided according to local protocols and
regulations, taking into account generic antibiotic resistance (Aslam
et al., 2018) and the lack of studies on the effect on the uterine
environment.
Further evidence (studies or observational/audit data) should be
collected on infection rates and their association with antibiotic
administration.
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Change to transmyometrial or laparoscopic oocyte retrieval
In exceptional cases, transmyometrial or laparoscopic oocyte retrieval
may be required, usually due to abnormal ovarian placement or tubal
adhesions. For transmyometrial OPU, there were no significant differ-
ences in oocyte recovery rates, implantation rates and pregnancy rates
compared to transvaginal OPU (Davis and Ginsburg, 2004; Roman-Ro-
driguez et al., 2015). An anaesthesiologist may be present during the
procedure, depending on local protocol.
OPU procedure
Setting and image optimization
– The surgical theatre/procedure room for OPU should be of
reasonable size and in semi-darkness, as this allows a better visu-
alization of the US images and the hypothetical adverse effect of
the light into the oocytes is precluded. The preferred temperature
is about 22–23◦C and, if necessary, a warming blanket and socks
can be used by the patient. Hypothermia has been associated with
increased perception of pain.
– During OPU, the US field and anatomical orientation are set from
the top or from the lower part of the monitor. The representation
of the transducer from the lower part of the monitor may help the
controlled manipulation of the transducer. The initial structures
are seen exactly at the beginning of the transducer as seen in the
monitor, and the tactile sensation during the scanning and needle
manipulation is more realistically represented. This point is very
important as the anatomy is better visualized, which is of crucial
importance for safety of the procedure. The laterality is again a par-
ameter that can be set depending on the operator’s preference.
– Before starting the surgical procedure, the pelvis should be sys-
tematically scanned to assess the anatomy and check for incidental
findings. Special attention should be focused on identification of
big iliac vessels to avoid incorrect interpretation as a follicle. The
needle guide track should be on the screen. It is relevant to first
have a panoramic view of the ovary and then have a closer look.
A larger view field is preferable during the OPU—magnify until
the whole ovary occupies 75% of the field (depending on the
dynamics of the ovary)—to ensure visualization of the intrapelvic
part of the needle during the OPU.
– In case of doubt, Doppler study is advised for recognition of the
vascular structures [positioned in the line between transducer (vag-
inal wall) and ovary] and to reduce the risk of haemorrhagic com-
plications (Risquez and Confino, 2010). Using Doppler imaging
during the OPU procedure may be seen as an additional complex
study to perform, switching from bi-dimensional to Doppler
image, and it is not recommended to do this during the OPU. How-
ever, Doppler study can be useful to detect vascular areas in case
of doubt in 2D-US imaging before OPU. It could differentiate the
hypo-echogenic areas that look alike, such as superficial follicles
versus iliac or para-ovarian vessels (position, content, fluid move-
ment).Furtherresearch isneededtodeterminewhether thismodal-
ity of imaging needs to be applied routinely before starting OPU in
order to furtherdecreasetherisksof an accidental vascular trauma.
– Information regarding the peri-follicular Doppler vascularization,
before OPU, could be used for academic purposes (for instance





























































































































– Adaptation of the US frequency with other image adjustments
should be considered in real time to improve the clarity of the
image and facilitate the accurate visualization of the needle. The
US frequency used for OPU varies between 5 and 7 MHz to obtain
sufficientresolutionanddepthof penetration.Additional filters and
image adjustment set-ups can be activated to improve the image.
– Recording the OPU procedure can be a useful audit tool for quality
control of the US image, learning and teaching as well as to explore
factors related to complications. Video recording can be used
in prevention of future complications and improvement of OPU
techniques.
Technique
– The transvaginal ultrasonographic transducer must be gently
applied well into the vaginal wall in order to position the ovary just
adjacent to vaginal fornices. There should be no space between
the vaginal transducer and ovarian cortex, thus avoiding any bowel
loop within the trajectory of the needle. To stabilize the ovary in
one place, external abdominal pressure or supra-pubic pressure
can be applied (with the help of an assistant) towards the vaginal
fornix of the patient by the site (right or left) where OPU is
performed. This can move the ovarian follicles closer to the
vaginal wall, thereby avoiding multiple ovarian punctures. Push
the puncture needle through the needle guide to the vaginal top
and gently puncture the vaginal wall until just below the ovary,
then puncture the nearest follicle in one movement.
– The operator needs to be familiar with the tactile resistance
when the follicle/ovary is penetrated by the needle and able
to manipulate the transducer, which produces the US image. A
fingertip handle on the distal end of the needle can facilitate the
puncture with good clinical touch. In case of resistance or hard-to-
reach follicle(s), one should pull back the needle in one movement.
– Techniques for tracking the needle (edging) should be used. The
edging of the needle should always be visible.
– Follicle curetting involves gently and rapidly rotating the needle in
a clockwise and counter-clockwise fashion inside the follicle after
complete aspiration of the follicular fluid (Yao and Schust, 2002).
It has been suggested (in a single retrospective study) that follicle
curetting during OPU could increase the number of recovered
oocytes as well as the number of mature oocytes, without dam-
aging the oocyte, and prevent adhesion of the granulosa cell layer
to the needle lumen, which could block it during aspiration (Dahl
et al., 2009). More studies are needed to confirm the clinical value
and safety of this technique.
– Vacuum suction should be used just before the follicle penetration.
The pressure of the pump suction must be calibrated to 100–
220 mmHg (according to manufacturer’s instructions) just before
starting, and it should be kept constant during the procedure.
The pedal for the pump can be controlled by the operator or
by an assistant. Collapse of the follicle should be visualized when
aspirating in order not to lose oocytes. If the collapse of the follicle
cannot be seen, the oocyte can remain in the follicular cavity.
– The needle should be gently withdrawn without negative suction
pressure to avoid sudden forward flow of follicular fluid towards
the collection tube (Horne et al., 1996). The movement of the
hand holding the transducer should be minimal when the needle
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is in the ovary. Lateral movements cause more pain and can result
in increased intra-ovarian bleeding.
– Small follicles (<10 mm) can be left un-punctured (to avoid
collection of immature eggs), unless there is a high risk of ovarian
hyper-stimulation syndrome (OHSS).
– Experts prefer to start the OPU from the ovary nearest to the vagi-
nal probe rather than the ovary with the largest follicles or com-
plexappearances,because in hyper-stimulated ovaries, sometimes
the length of needle cannot reach the length of ovary, and the
procedure can be dangerous if near vascular structures. The lat-
erality, whether to prefer the right versus the left ovary, is based on
operator’s preferences rather than on anatomical considerations.
– One should use both planes, longitudinal and transverse, while
performing the OPU in order to be sure about the anatomy and
boundaries of the ovarian cortex.
– It is preferred to maintain the needle within the ovary—avoiding
repetitive punctures or ovarian penetrations—during the OPU
as this could reduce the risk of complications, mainly ovarian
surface bleeding. Multiple punctures should be avoided as much
as possible.
– It is recommended to access as many follicles as is safely possible
through the same ovarian cortex puncture.
– Manipulation of the OPU needle should be gentle and steady,
avoiding abrupt movements.
Flushing
– Follicular flushing has been proposed to increase the number of
retrieved oocytes. Closed flushing (i.e. every follicle is rinsed three
to four times, and tubes are passed on to the laboratory when
all follicles are punctured) has been recommended for patients
with >6 follicles, and open flushing (i.e. with direct communication
between the laboratory staff and the operator, the follicle is rinsed
until an oocyte is detected in the laboratory, or until no cell
material is detected) for those with ≤6 follicles. However, studies
on flushing performed failed to show any benefit (Georgiou et al.,
2018). The results of this technique should be audited regularly.
Flushing needs to be performed with a double-lumen needle to
reduce damage to the oocyte.
Oocyte recovery
– The follicular fluid should be collected in preheated test tubes held
in a heating block calibrated at 37◦C.
– Embryology laboratory staff should inform the medical doctor of
oocytes and granulosa cells during the OPU procedure in order
to differentiate empty follicle syndrome and wrong timing of hCG
injection.
– In case of suspected premature ovulation, peritoneal fluid can be
aspirated at the end of OPU in search of additional oocytes that
could have been ovulated or fallen into the peritoneal cavity during
the procedure.
End of procedure
– At the end of the procedure, the ovary should be checked to see
whether all follicles were punctured and to detect any internal
bleeding.






























































































































– If abdominal bleeding is suspected, transabdominal US should be
performed before moving the patient.
– Post-OPU vaginal compression with a swab may enhance
haemostasis and stop potential vaginal bleeding, which may
otherwise be a disturbing finding for the couple after OPU. With
prolonged bleeding, packing can be applied (No, 2016). A pad can
also be used after vaginal compression for monitoring of vaginal
bleeding. If necessary, a haemostatic suture is placed.
– Post-OPU analgesia (paracetamol, ibuprofen) should be consid-
ered, especially in cases where more than 10 oocytes are retrieved
and in patients with endometriosis.
– The proportion of OPUs without obtaining an oocyte is usually 1–
2% (Ben-Shlomo et al., 1991; Traina et al., 1993; Matorras et al.,
2012). This lack of oocyte recovery is much more common in
women with few adequately sized follicles (Zreik et al., 2000). It
has been reported that in 5–20% of dominant adequately sized
follicles, no oocytes are retrieved (Nargund et al., 2001; Coskun
et al., 2010; Coskun et al., 2011). Furthermore, poor respon-
ders may have an increased rate of impaired folliculogenesis and
oocytes may have lower quality (Matorras et al., 2014) (Fig. 3).
– hCG determination is mandatory for patients with no
oocyte retrieval in hCG-triggered cycles, to assess the
correct hCG administration. No oocyte retrieval with
high hCG levels could indicate an ectopic pregnancy
(Bringer-Deutsch et al., 2010).
– In cases where OPU failed to recover oocytes and the
administration of the medication was adequate, performing
a (rescue) IUI is associated with very low pregnancy rates
(<7%) and should not be carried out (Matorras et al., 2014).
Post-procedure care
– After theprocedure,patients shouldremain in bed at the centre for
recovery (about 2 h, or less if the procedure was performed with
localanaestheticsonly).General status,abdominaldistension,blood
pressure and heart rate should be monitored by a nurse (Fig. 4).
– In cases of significant pain or abdominal distension, a blood
analysis and/or an US scan should be performed before discharge
to check for potential intra-abdominal bleeding.
– Patients should be able to eat, drink and pass urine before dis-
charge. Furthermore, it is important to check awareness, orienta-
tion and respiratory rate. A written information leaflet about post-
care procedures, complications and a 24-h emergency number
should be provided.
– In patients with haematoma, bleeding or infection after the OPU,
antibiotic coverage is recommended.
– Procedures should be in place when severe complications occur,
including hospital admission arrangements, specialist responsibility
and continued care.
Associated pathologies and cautions during
OPU
– Standard management of hydrosalpinx should be removal or
clipping before OPU (Song et al., 2017). When a hydrosalpinx is
only discovered during OPU, the first option should be oocyte or
embryo cryopreservation. The benefit of aspiration on the day of
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OPU needs further study (Hammadieh et al., 2008; Fouda et al.,
2015; Zhou et al., 2016).
– Patients with potential infectious risk (HIV, hepatitis) should be
managed in an isolated circuit or in specialized centres to avoid
cross-contamination.
– In women with endometriosis, OPU can be challenging and it
may affect the individual operator’s or centre’s performance rate
(Kasapoglu et al., 2018). Endometriomas should not be aspi-
rated. During OPU, the puncture of endometriomas should be
avoided to prevent contamination of the follicular aspirate and
reduce the risk of intra-abdominal infection. However, piercing
the endometrioma is often the only way to avoid losing an
important number of oocytes. Dermoid cysts should not be punc-
tured during OPU, since this could increase the risk of PID and
peritonitis. In patients with an endometrioma or teratoma, the risk
of PID is increased, even if they have not been punctured (Moini
et al., 2005; Benaglia et al., 2008; Villette et al., 2016; Kasapoglu
et al., 2018). These patients should be counselled preoperatively
and consent obtained appropriately.
– If an endometrioma or a haemorrhagic follicle is inadver-
tently punctured, the needle should be immediately withdrawn
and flushed with media, and the collecting tube should be changed.
– In patients with borderline ovarian tumours, it is unclear whether
ART procedures are associated with an increased risk of recur-
rence (Denschlag et al., 2010).
– Increased risk for bleeding has been suggested in lean women, and
in women with polycystic ovary syndrome (Liberty et al., 2010;
Zhen et al., 2010).
Complications and risks
ESHRE IVF monitoring (EIM) data collection reports data on complica-
tions from OPU. In the latest data available, including 776 556 cycles,
complications from OPU were reported in 1328 cycles (0.17%), includ-
ing 919 bleeding (0.11% of cycles), 108 infections (0.013%) and 301
(0.038%) other complications. There were three maternal deaths
reported as complications of ART, but none were related to the OPU
procedure (De Geyter et al., 2018).
Large observational studies in oocyte donors undergoing OPU have
reported low incidences of complications (0.42% in Bodri et al. (2008),
0.7% in Maxwell et al. (2008)). The most common reported compli-
cations were OHSS (although a complication of ovarian stimulation
rather than OPU) and intra-abdominal bleeding. Large observational
studies have also been conducted (Table III). Overall, the incidence and
severity of the reported complications are low (Ludwig et al., 2006;
Aragona et al., 2011; Siristatidis et al., 2013; Ozaltin et al., 2018).
Associated conditions may increase the risk of complications, but
very little information is available, and over- and under-reporting have
been suggested (Villette et al., 2016). Recommendations regarding
associated conditions during OPU have been addressed above.
Apart from data collection and observational studies (Ludwig et al.,
2006, Aragona et al., 2011, Siristatidis et al., 2013, Ozaltin et al., 2018),
most reports on serious complications during and after OPU have been
published in case reports (Table IV). Reported complications include
bleeding, infection, urinary tract injury and pseudoaneurysm.
– Infection: an infection can originate from the vaginal puncture





























































































































vaginal bacteria into the intra-peritoneal space (Kelada and Ghani,
2007). The presence of pre-existent latent pelvic infection or
pelvic endometriosis or teratoma may be another contributing
factor. In some difficult cases, puncture of hydrosalpinx or an acci-
dental puncture of an attached bowel loop during the procedure
may occur, which may lead to severe septicaemia (Amso, 1995).
– Bleeding: the quantity of blood loss following OPU is clinically
unremarkable in most women. In a prospective study of 150
consecutive OPUs, the estimated median blood loss was 72 ml
(interquartile range 8–162 ml) (Ragni et al., 2009). None of the
recruited women was found to have signs of haemoperitoneum
(Ragni et al., 2009). Haemoperitoneum after OPU has been
defined as a haemoglobin reduction of >2 g/day, an increase
in the pelvic-free fluid of >200 ml or a calculated blood loss of
>500 ml.
– After para-cervical block, a transient leg paresis may develop,
which usually disappears after 2–4 h.
– The IVF centre should have proactively established policies with
respect to how to provide patient resuscitation and access to
surgical theatre in case of internal bleeding or other organ injury
in a haemodynamically unstable patient (safety standard).
– OPU video recording may help to identify reasons for complica-
tions and how to improve the OPU technique with respect to US
settings for clear imaging and types of manoeuvres during oocyte
aspiration.
All severe complications should be registered according to local
requirements. It is recommended that more details on severe com-
plications are gathered from the EIM data collection.
Future developments
– Doppler studies can be useful to detect vascular areas in case
of doubt in 2D-US imaging. Doppler could differentiate hypo-
echogenic areas that look alike, such as superficial follicles versus
iliac or para-ovarian vessels (position, content, fluid movement).
Further research is needed to determine whether this modality of
imaging needs to be applied routinely during OPU.
– Artificial intelligence, based on US features, patient profile and
biochemical metrics information, can be used as a predictor
of how much the follicle grows in the next few days. Artificial
intelligence here can be very useful when predicting the growth
of poor responders’ follicles, and this can be a direction for future
research. Another application could be to classify the follicles
during the process of growth and use this information in OPU
and embryo selection for transfer.
Training and competence
OPU should be performed by doctors competently trained in repro-
ductive medicine. In some European countries, fertility specialist or
nurses can be trained to perform OPU. This depends on local regu-
lations and on clinical practice.
There are currently no generally accepted minimal requirements for
OPU training; the Royal College of Obstetricians and Gynaecologists
(RCOG) sub-specialty curriculum does not contain any specific min-
imum number of OPUs to be performed (RCOG, 2015), nor does
the recent AIUM Practice Parameter for Ultrasound Examinations in
Good practice in US-guided OPU 13
















Related to sedation, anaesthesia 14 (0.06%) 0 2 (0.36%) 0
Vaginal bleeding 2 (0.01%) 32 (3.1%) 98 (18.08%) 29 (2.8%)
Intra-abdominal/intra-peritoneal
bleeding
54 (0.23%) 0 2 (0.36%) 4 (0.06%) 0
Injury of pelvic structures 2 (0.01%) 0 1 (0.1%)
Pelvic abscess 2 (0.19%) 0
Ovarian abscess 2 (0.03%)
Pelvic infections 10 (0.04%) 8 (0.77%) 0 0
Severe pain (requiring
hospitalization)
14 (0.06%) 1 (0.09%) 0 7 (0.7%)
OHSS (all) 47 (4.55%) 17 (3.24%) 28 (2.7%)
OPU: oocyte pick up; OHSS: ovarian hyper-stimulation syndrome.
∗Only intra-peritoneal bleeding and pelvic abscess were reported.
Reproductive Medicine and Infertility (American Institute of Ultra-
sound in Medicine, 2017).
– For safety reasons, and wherever feasible, the simulator could be
the initial part of a structured training for novices who want to
perform OPU, enabling them to acquire basic skills and to reach a
predefined level of performance in a safe and controlled environ-
ment, before applying the procedure to real patients (Soave et al.,
2019).
– Adequate training in OPU includes basic training in IVF US, and at
least 30 OPU procedures should be performed under supervision
to reach the minimum criteria for competency (but this can vary
depending on the type of training, background and progress of
trainees) and at least 50 OPUs should be performed indepen-
dently before the acquirement of the qualification.
– Proficiency has been defined as retrieving ≥80% of the oocytes
compared with a senior operator performing OPU in the con-
tralateral ovary (Dessolle et al., 2014) (see also Fig. 5).
– Maintaining skills is essential, aiming for at least 50 OPUs per year.
If this cannot be achieved, additional simulator training can be
helpful.
– To reach an expert level in OPU, at least 250 OPUs should be
performed, based on a large retrospective analysis showing an
association of the expertise of the operator with the risk of com-
plications, and significantly fewer complications if the operator has
performed at least 250 OPUs (Levi-Setti et al., 2018).
Quality assurance and performance
Good practice suggests keeping clear and readable documentation
regarding the OPU description with images and results (fx how many
oocytes obtained, difficulties during the procedure, information for
future audit or research, information about the equipment). Forms













































































Quality assurance in OPU performance should analyze key clinical
performance indicators, and it should be undertaken at least once per
year in the IVF centre. A list of key performance indicators for ART,
including US-guided OPU, will be published shortly.
The entire OPU procedure should be audited at least once
a year. This can be carried out by external auditors or quality
managers, or by members of the same team observing each other
performing the procedure (Human Fertilisation and Embryology
Authority, 2017).
Discussion
This paper provides good practice recommendations for US-guided
OPU. A literature search for evidence of the key aspects of the
procedure revealed that there was a scarcity of studies on the actual
procedural OPU technique. Selected papers (n = 190) relevant to the
topic were analyzed by the WG. The WG members considered the
following key points in the papers: whether US practice standards
were explained; to what extent the OPU technique was described and
whether complications or incidents and how to prevent such events
were reported. In the end, only 108 papers could be used to support
the recommendations in this document.
Most evidence focussed on comparing different equipment (needles)
and on complications and risks, including the risk of infection. For
these topics, the recommendations were largely based on the results
of the studies. Evidence for the other aspects was limited, and these
recommendations were based mainly on expert opinion, considering
whatever (indirect) evidence was available (Fig. 6).
One of the major research gaps was training and competence.
Training and OPU proficiency appeared to be less specific and new
more objective ways of evaluating performance should be used in
future. Newer technologies, such as simulation training, could help to
improve and standardize future training.


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Good practice in US-guided OPU 21
The current recommendations were aimed to support clinics in
assessing their OPU procedures and to update them to the highest
standards of patient care. In addition, this paper has outlined a list
of research priorities, which if conducted in future might support
confirmation or changes to the current recommendations.
Supplementary data
Supplementary data are available at Human Reproduction Open online.
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